Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 26.67%-451.03K | 77.75%-81.19K | -414.42%-102.36K | 12.22%-96.62K | -42.19%-170.86K | -95.41%-615.07K | -159.48%-364.94K | 33.34%-19.9K | -201.38%-110.07K | -11.52%-120.16K |
| Net income from continuing operations | -174.73%-488.32K | 60.23%-128.51K | -46.36%-120.59K | 1.33%-108.54K | -111.18%-130.69K | 192.17%653.47K | -31.26%-323.15K | 40.33%-82.39K | 29.07%-110.01K | 789.17%1.17M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---1.33M | --0 | ---- | ---- | ---1.33M |
| Depreciation and amortization | -20.05%889 | -20.14%222 | -19.86%222 | -19.78%223 | -20.43%222 | -19.94%1.11K | -19.88%278 | -20.17%277 | -19.88%278 | -19.83%279 |
| Remuneration paid in stock | 1,352.49%86.09K | 6,276.15%42.78K | 4,260.47%42.47K | -77.12%218 | -81.50%616 | -84.25%5.93K | -84.95%671 | -86.84%974 | -89.64%953 | -79.90%3.33K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | -103.35%-12.31K | -201.87%-107.73K | -51.92%50.84K | -53.73%48.66K | -108.04%-4.08K |
| Change In working capital | -173.37%-49.69K | -93.37%4.31K | -335.33%-24.47K | 122.98%11.48K | -196.97%-41.01K | 655.79%67.73K | 1,397.23%64.99K | 297.25%10.4K | -1,394.43%-49.95K | 833.82%42.29K |
| -Change in receivables | 324.27%24.63K | 132.88%7.99K | 304.91%8.57K | -550.10%-12.98K | 153.53%21.05K | 15.56%-10.98K | -78.71%-24.29K | 36.05%2.12K | 1,316.88%2.88K | 1,229.80%8.3K |
| -Change in prepaid assets | -1,927.35%-4.74K | -60.61%2.9K | -277.01%-13.01K | 157.25%7.35K | 5.63%-1.98K | 64.76%-234 | 1.60%7.35K | 159.39%7.35K | -286.01%-12.84K | 13.53%-2.1K |
| -Change in payables and accrued expense | -188.14%-69.58K | -108.02%-6.57K | -2,253.76%-20.03K | 142.77%17.11K | -266.52%-60.08K | 5,219.68%78.94K | 5,995.68%81.93K | -83.25%930 | -1,324.29%-39.99K | 1,485.64%36.08K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 26.67%-451.03K | 77.75%-81.19K | -414.42%-102.36K | 12.22%-96.62K | -42.19%-170.86K | -95.41%-615.07K | -159.48%-364.94K | 33.34%-19.9K | -201.38%-110.07K | -11.52%-120.16K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 1,263.46%245.42K | 0 | 5,153.84%236.42K | 0.00%4.5K | 0.00%4.5K |
| Interest received (cash flow from investment activities) | --0 | --0 | --0 | --0 | --0 | -24.88%12.31K | --0 | 1.64%4.16K | -0.71%4.07K | -0.71%4.08K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | 14,290.00%233.12K | --0 | 56,688.51%232.27K | 7.23%430 | 7.36%423 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 1,263.46%245.42K | --0 | 5,153.84%236.42K | 0.00%4.5K | 0.00%4.5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -0.89%581.86K | 101.44%581.86K | 0 | 0 | |||||
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -1.32%597K | 95.74%597K | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 15.41%-15.14K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | ---- | ---- | -0.89%581.86K | 101.44%581.86K | --0 | --0 | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 44.38%690.42K | -32.30%320.58K | 64.59%422.94K | 43.31%519.56K | 44.38%690.42K | 154.55%478.2K | 45.47%473.5K | -26.76%256.97K | -5.31%362.54K | 154.55%478.2K |
| Current changes in cash | -312.54%-451.03K | -137.43%-81.19K | -147.28%-102.36K | 8.48%-96.62K | -47.72%-170.86K | -26.91%212.22K | 42.05%216.92K | 954.10%216.52K | -229.68%-105.57K | -159.31%-115.66K |
| End cash Position | -65.33%239.39K | -65.33%239.39K | -32.30%320.58K | 64.59%422.94K | 43.31%519.56K | 44.38%690.42K | 44.38%690.42K | 45.47%473.5K | -26.76%256.97K | -5.31%362.54K |
| Free cash from | 26.67%-451.03K | 77.75%-81.19K | -414.42%-102.36K | 12.22%-96.62K | -42.19%-170.86K | -95.41%-615.07K | -159.48%-364.94K | 33.34%-19.9K | -201.38%-110.07K | -11.52%-120.16K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.